dxa Search Results


91
ProSci Incorporated hla dqa2
The hazard rate of genes for glioma patients with IDH1mt.
Hla Dqa2, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla dqa2/product/ProSci Incorporated
Average 91 stars, based on 1 article reviews
hla dqa2 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

90
Hormel Health Labs the dxa instrument was calibrated monthly by using a series of beef blocks of known composition
The hazard rate of genes for glioma patients with IDH1mt.
The Dxa Instrument Was Calibrated Monthly By Using A Series Of Beef Blocks Of Known Composition, supplied by Hormel Health Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the dxa instrument was calibrated monthly by using a series of beef blocks of known composition/product/Hormel Health Labs
Average 90 stars, based on 1 article reviews
the dxa instrument was calibrated monthly by using a series of beef blocks of known composition - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Hologic Inc dxa instruments
The hazard rate of genes for glioma patients with IDH1mt.
Dxa Instruments, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dxa instruments/product/Hologic Inc
Average 90 stars, based on 1 article reviews
dxa instruments - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Faxitron Bioptics dxa digital radiography system
The hazard rate of genes for glioma patients with IDH1mt.
Dxa Digital Radiography System, supplied by Faxitron Bioptics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dxa digital radiography system/product/Faxitron Bioptics
Average 90 stars, based on 1 article reviews
dxa digital radiography system - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Sternberger Monoclonals dxa
The hazard rate of genes for glioma patients with IDH1mt.
Dxa, supplied by Sternberger Monoclonals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dxa/product/Sternberger Monoclonals
Average 90 stars, based on 1 article reviews
dxa - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Hologic Inc discovery a dual-energy x-ray absorptiometer
The hazard rate of genes for glioma patients with IDH1mt.
Discovery A Dual Energy X Ray Absorptiometer, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/discovery a dual-energy x-ray absorptiometer/product/Hologic Inc
Average 90 stars, based on 1 article reviews
discovery a dual-energy x-ray absorptiometer - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Hologic Inc dxa qr 4500
The hazard rate of genes for glioma patients with IDH1mt.
Dxa Qr 4500, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dxa qr 4500/product/Hologic Inc
Average 90 stars, based on 1 article reviews
dxa qr 4500 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Hologic Inc dxa equipment discovery w
The hazard rate of genes for glioma patients with IDH1mt.
Dxa Equipment Discovery W, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dxa equipment discovery w/product/Hologic Inc
Average 90 stars, based on 1 article reviews
dxa equipment discovery w - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
OVITO GmbH dxa analysis tool
The hazard rate of genes for glioma patients with IDH1mt.
Dxa Analysis Tool, supplied by OVITO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dxa analysis tool/product/OVITO GmbH
Average 90 stars, based on 1 article reviews
dxa analysis tool - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Stratec Biological peripheral dual-energy xray absorptiometry
The hazard rate of genes for glioma patients with IDH1mt.
Peripheral Dual Energy Xray Absorptiometry, supplied by Stratec Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peripheral dual-energy xray absorptiometry/product/Stratec Biological
Average 90 stars, based on 1 article reviews
peripheral dual-energy xray absorptiometry - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Hologic Inc dxa machine explorer
The hazard rate of genes for glioma patients with IDH1mt.
Dxa Machine Explorer, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dxa machine explorer/product/Hologic Inc
Average 90 stars, based on 1 article reviews
dxa machine explorer - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Faxitron Bioptics small animal ultra-high-resolution imaging and dual-energy x-ray absorptiometry (dxa) system faxitron ultrafocus
The hazard rate of genes for glioma patients with IDH1mt.
Small Animal Ultra High Resolution Imaging And Dual Energy X Ray Absorptiometry (Dxa) System Faxitron Ultrafocus, supplied by Faxitron Bioptics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small animal ultra-high-resolution imaging and dual-energy x-ray absorptiometry (dxa) system faxitron ultrafocus/product/Faxitron Bioptics
Average 90 stars, based on 1 article reviews
small animal ultra-high-resolution imaging and dual-energy x-ray absorptiometry (dxa) system faxitron ultrafocus - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


The hazard rate of genes for glioma patients with IDH1mt.

Journal: Frontiers in Immunology

Article Title: A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy

doi: 10.3389/fimmu.2022.1001381

Figure Lengend Snippet: The hazard rate of genes for glioma patients with IDH1mt.

Article Snippet: Primary antibodies used were as follows: HLA-DQA2 (1:200; Cat No. 42-669, ProSci, Fort Collins, CO, USA), HOXA3 (1:100; Cat No.ab230879, Abcam, Cambridge, UK), SAA2 (1:500; Cat No. CAU25292; Biomatik, Kitchener, Canada), CD8 (1:4000; Cat No. 66868-1-Ig; Proteintech, Wuhan, China), and CD86 (1:250; Cat No. ab220188, Abcam).

Techniques:

Hub genes selected to construct the risk model. (A, B) LASSO analysis for hub genes associated with the survival rate of IDH1mt-glioma patients. (C) Multivariate Cox regression analysis of HLA-DQA2 , HOXA3 , and SAA2. These three genes were used to construct the risk model.

Journal: Frontiers in Immunology

Article Title: A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy

doi: 10.3389/fimmu.2022.1001381

Figure Lengend Snippet: Hub genes selected to construct the risk model. (A, B) LASSO analysis for hub genes associated with the survival rate of IDH1mt-glioma patients. (C) Multivariate Cox regression analysis of HLA-DQA2 , HOXA3 , and SAA2. These three genes were used to construct the risk model.

Article Snippet: Primary antibodies used were as follows: HLA-DQA2 (1:200; Cat No. 42-669, ProSci, Fort Collins, CO, USA), HOXA3 (1:100; Cat No.ab230879, Abcam, Cambridge, UK), SAA2 (1:500; Cat No. CAU25292; Biomatik, Kitchener, Canada), CD8 (1:4000; Cat No. 66868-1-Ig; Proteintech, Wuhan, China), and CD86 (1:250; Cat No. ab220188, Abcam).

Techniques: Construct

Expression of HLA-DQA2 , HOXA3 , SAA2 , CD86 , and CD8 in IDH1mt-glioma tissues. IDH1mt-glioma tissues were divided into long- and short-term survival groups according to the patient’s number of days of survival with the cut-off as 15 months. (A) The IHC score of HLA-DQA2 , HOXA3 , and SAA2 in IDH1mt-glioma tissues in long- and short-term groups. (B) Representative figures of expression of HLA-DQA2 , HOXA3 , and SAA2 in long- and short-term group IDH1mt-glioma tissues. (C) Expression of CD86 and CD8 in long- and short-term group IDH1mt-glioma tissues. (D–F) The diagnostic value of HLA-DQA2 , HOXA3 , and SAA2 for distinguishing long- and short-term survival of IDH1mt-glioma patients. ** P < 0.01.

Journal: Frontiers in Immunology

Article Title: A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy

doi: 10.3389/fimmu.2022.1001381

Figure Lengend Snippet: Expression of HLA-DQA2 , HOXA3 , SAA2 , CD86 , and CD8 in IDH1mt-glioma tissues. IDH1mt-glioma tissues were divided into long- and short-term survival groups according to the patient’s number of days of survival with the cut-off as 15 months. (A) The IHC score of HLA-DQA2 , HOXA3 , and SAA2 in IDH1mt-glioma tissues in long- and short-term groups. (B) Representative figures of expression of HLA-DQA2 , HOXA3 , and SAA2 in long- and short-term group IDH1mt-glioma tissues. (C) Expression of CD86 and CD8 in long- and short-term group IDH1mt-glioma tissues. (D–F) The diagnostic value of HLA-DQA2 , HOXA3 , and SAA2 for distinguishing long- and short-term survival of IDH1mt-glioma patients. ** P < 0.01.

Article Snippet: Primary antibodies used were as follows: HLA-DQA2 (1:200; Cat No. 42-669, ProSci, Fort Collins, CO, USA), HOXA3 (1:100; Cat No.ab230879, Abcam, Cambridge, UK), SAA2 (1:500; Cat No. CAU25292; Biomatik, Kitchener, Canada), CD8 (1:4000; Cat No. 66868-1-Ig; Proteintech, Wuhan, China), and CD86 (1:250; Cat No. ab220188, Abcam).

Techniques: Expressing, Diagnostic Assay